Intake of coffee, caffeine and other methylxanthines and risk of Type i vs Type II endometrial cancer

British Journal of Cancer

Volumn 109, Issue 7, 2013, Pages 1908-1913

  Uccella, S ^a   Mariani, A ^a   Wang, A H ^b   Vierkant, R A ^b   Cliby, W A ^a   Robien, K ^c   Anderson, K E ^c   Cerhan, J R ^b  

^a Division of Gynecologic Surgery   (United States)

^b Mayo Clinic   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

caffeine; coffee; cola; decaffeinated coffee; endometrial cancer; methylxanthines; tea

Indexed keywords

CAFFEINE; METHYLXANTHINE;

ADULT; AGED; ARTICLE; BODY MASS; CACAO; CANCER RISK; COFFEE; COHORT ANALYSIS; COLA; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; TEA;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; CAFFEINE; COFFEE; EATING; ENDOMETRIAL NEOPLASMS; FEMALE; FOOD PREFERENCES; HUMANS; MIDDLE AGED; OBESITY; POSTMENOPAUSE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; XANTHINES;

EID: 84885179880     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.540     Document Type: Article

References (25)

1. Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15(1): 10-17.
2. Bushman JL (1998) Green tea and cancer in humans: a review of the literature. Nutr Cancer 31(3): 151-159.
3. Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, Schilter B (2002) Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 40(8): 1155-1163.
4. Doll A, Abal M, Rigau M, Monge M, Gonzalez M, Demajo S, Colas E, Llaurado M, Alazzouzi H, Planaguma J, Lohmann MA, Garcia J, Castellvi S, Ramon y Cajal J, Gil-Moreno A, Xercavins J, Alameda F, Reventos J (2008) Novel molecular profiles of endometrial cancer-new light through old windows. J Steroid Biochem Mol Biol 108(3-5): 221-229.
5. Ferrini RL, Barrett-Connor E (1996) Caffeine intake and endogenous sex steroid levels in postmenopausal women. The Rancho Bernardo Study. Am J Epidemiol 144(7): 642-644.
6. Folsom AR, Kaye SA, Prineas RJ, Potter JD, Gapstur SM, Wallace RB (1990) Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol 131(5): 794-803.
7. Friberg E, Orsini N, Mantzoros CS, Wolk A (2009) Coffee drinking and risk of endometrial cancer-a population-based cohort study. Int J Cancer 125(10): 2413-2417.
8. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S (2000) International Classification of Diseases for Oncology. 3rd edn. World Health Organization: Geneva, Switzerland.
9. Giri A, Sturgeon SR, Luisi N, Bertone-Johnson E, Balasubramanian R, Reeves KW (2011) Caffeinated coffee, decaffeinated coffee and endometrial cancer risk: a prospective cohort study among US postmenopausal women. Nutrients 3(11): 937-950.
10. Gunter MJ, Schaub JA, Xue X, Freedman ND, Gaudet MM, Rohan TE, Hollenbeck AR, Sinha R (2011) A prospective investigation of coffee drinking and endometrial cancer incidence. Int J Cancer 131: E530-E536.
11. He Z, Ma WY, Hashimoto T, Bode AM, Yang CS, Dong Z (2003) Induction of apoptosis by caffeine is mediated by the p53, Bax, and caspase 3 pathways. Cancer Res 63(15): 4396-4401.
12. Huxley R, Lee CM, Barzi F, Timmermeister L, Czernichow S, Perkovic V, Grobbee DE, Batty D, Woodward M (2009) Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med 169(22): 2053-2063.
13. Je Y, Giovannucci E (2011) Coffee consumption and risk of endometrial cancer: findings from a large up-to-date meta-analysis. Int J Cancer 131(7): 1700-1710.
14. Je Y, Hankinson SE, Tworoger SS, DeVivo I, Giovannucci E (2011) A prospective cohort study of coffee consumption and risk of endometrial cancer over a 26-year follow-up. Cancer Epidemiol Biomarkers Prev 20: 2487-2495.
15. Korn EL, Graubard BI, Midthune D (1997) Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 145(1): 72-80.
16. La Vecchia C, Tavani A (2007) Coffee and cancer risk: an update. Eur J Cancer Prev 16(5): 385-389.
17. Loopstra-Masters RC, Liese AD, Haffner SM, Wagenknecht LE, Hanley AJ (2011) Associations between the intake of caffeinated and decaffeinated coffee and measures of insulin sensitivity and beta cell function. Diabetologia 54(2): 320-328.
18. Lunn M, McNeil D (1995) Applying Cox regression to competing risks. Biometrics 51(2): 524-532.
19. Mendivil A, Schuler KM, Gehrig PA (2009) Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes. Cancer Control 16(1): 46-52.
20. Munger RG, Folsom AR, Kushi LH, Kaye SA, Sellers TA (1992) Dietary assessment of older Iowa women with a food frequency questionnaire: nutrient intake, reproducibility, and comparison with 24-hour dietary recall interviews. Am J Epidemiol 136(2): 192-200.
21. Nagata C, Kabuto M, Shimizu H (1998) Association of coffee, green tea, and caffeine intakes with serum concentrations of estradiol and sex hormonebinding globulin in premenopausal Japanese women. Nutr Cancer 30(1): 21-24.
22. Uccella S, Mariani A, Wang AH, Vierkant RA, Robien K, Anderson KE, Cerhan JR (2011) Dietary and supplemental intake of one-carbon nutrients and the risk of type I and type II endometrial cancer: a prospective cohort study. Ann Oncol 22(9): 2129-2136.
23. Vivani R (1993) The composition of coffee. In Caffeine, Coffee and Health, Garattini S (ed). pp 17-41. Rave Press Ltd: New York, NY, USA.
24. Willett WC, Sampson L, Browne ML, Stampfer MJ, Rosner B, Hennekens CH, Speizer FE (1988) The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol 127: 188-199.
25. Wu T, Willett WC, Hankinson SE, Giovannucci E (2005) Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in U.S. women. Diabetes Care 28(6): 1390-1396.